0001127602-17-012348.txt : 20170320
0001127602-17-012348.hdr.sgml : 20170320
20170320150153
ACCESSION NUMBER: 0001127602-17-012348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170316
FILED AS OF DATE: 20170320
DATE AS OF CHANGE: 20170320
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAAB THOMAS R II
CENTRAL INDEX KEY: 0001230708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 17701228
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-03-16
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001230708
STAAB THOMAS R II
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior Vice President and CFO
Common Stock
2017-03-16
4
M
0
23955
3.78
A
141268
D
Common Stock
2017-03-16
4
M
0
12500
1.42
A
153768
D
Common Stock
2017-03-16
4
F
0
12308
8.80
D
141460
D
Emp. Stock Option (Right to Buy)
3.78
2017-03-16
4
M
0
23955
0
D
2012-07-01
2021-07-01
Common Stock
23955
59055
D
Emp. Stock Option (Right to Buy)
1.42
2017-03-16
4
M
0
12500
0
D
2014-01-01
2023-01-01
Common Stock
12500
75000
D
Shares of Common Stock delivered to the Company to satisfy payment of exercise price in connection with stock option exercise.
/s/ Alane P. Barnes, by power of attorney
2017-03-20